Process evaluation of the data-driven quality improvement in primary care (DQIP) trial: Active and less active ingredients of a multi-component complex intervention to reduce high-risk primary care prescribing

Implementation Science

Volumn 12, Issue 1, 2017, Pages

  Grant, Aileen ^a   Dreischulte, Tobias ^b,c   Guthrie, Bruce ^c  

^a UNIVERSITY OF STIRLING   (United Kingdom)

^b NHS TAYSIDE   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Family practice; General practice; Prescribing; Process evaluation; Quality and safety; Randomised controlled trials

Indexed keywords

ANTITHROMBOCYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

CLINICAL COMPETENCE; CLINICAL PRACTICE; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED STUDY; ECONOMICS; EDUCATION; ENGLAND; GENERAL PRACTICE; HEALTH CARE QUALITY; HEALTH PERSONNEL ATTITUDE; HUMAN; MOTIVATION; MULTICENTER STUDY; PATIENT SAFETY; PRESCRIPTION; PRIMARY HEALTH CARE; PROCEDURES; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; RISK MANAGEMENT; SCOTLAND; STANDARDS; STATISTICS AND NUMERICAL DATA; UNNECESSARY PROCEDURE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATTITUDE OF HEALTH PERSONNEL; CLINICAL COMPETENCE; CLUSTER ANALYSIS; DRUG PRESCRIPTIONS; ENGLAND; GENERAL PRACTICE; HUMANS; MOTIVATION; NEWSPAPERS AS TOPIC; PATIENT SAFETY; PLATELET AGGREGATION INHIBITORS; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY HEALTH CARE; PROCESS ASSESSMENT (HEALTH CARE); RISK MANAGEMENT; SCOTLAND; UNNECESSARY PROCEDURES;

EID: 85010216419     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/s13012-016-0531-2     Document Type: Article

References (29)

1. Howard R, Avery A, Bissell P. Causes of preventable drug-related hospital admissions: a qualitative study. Qual Saf Health Care. 2008;17(2):109-16.
2. Hakkarainen KM, Hedna K, Petzold M, Hagg S. Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions-a meta-analysis. PLoS One. 2012;7(3):e33236.
3. National Institute for Health and Care Excellence (NICE). Costing statement: medicines optimisation-implementing the NICE guideline on medicines information (NG5). 2015. Available at https://www.nice.org.uk/guidance/ng5/resources/costing-statement-6916717. Accessed 5 Nov 2016.
4. Institute for Health Care Informatics, IMS. Responsible use of medicines report. 2012. http://www.imshealth.com/en/thought-leadership/ims-institute/reports/responsible-use-of-medicines-report. Accessed 8 Dec 2016.
5. Howard RL, Avery A, Slavenburg S, Royal S, Pipe G, Lucassen P, Pirohamed M. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2006;63:136-47.
6. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalisation for adverse drug events in older Americans. N Engl J Med. 2011;365(21):2002-12.
7. Leendertse AJ, Egberts ACG, Stoker LJ, van den Bent PM. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168(17):1890-6.
8. Guthrie B, McCowan C, Davey P, Simpson CR, Dreischulte T, Barnett K. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. Br Med J. 2011;342:d3514.
9. Dreischulte T, Grant A, Donnan P, McCowan C, Davey P, Petrie D, Treweek S, Guthrie B. A cluster randomised stepped wedge trial to evaluate the effectiveness of a multifaceted information technology-based intervention in reducing high-risk prescribing of non-steroidal anti-inflammatory drugs and antiplatelets in primary care: the DQIP study protocol. Implement Sci. 2012;7:24.
10. Grant AM, Guthrie B, Dreischulte T. Developing a complex intervention to improve prescribing safety in primary care: mixed methods feasibility and optimisation pilot study. BMJ Open 2014;4:e004153. doi: 10.1136/bmjopen-2013-004153.
11. Brown C, Lilford R. The stepped wedge trial design: a systematic review. BMC Med Res Methodol. 2006;6(1):54.
12. Dreischulte T, Donnan P, Grant A, Hapca A, McCowan C, Guthrie B. Safer prescribing-a trial of education, informatics and financial incentives. New England J Med. 2016;374:1053-64.
13. Dopson S, Locock L, Chambers D, Gabbay J. Implementation of evidence-based medicine: evaluation of the promoting action of clinical effectiveness programme. J Health Serv Res Policy. 2001;6:23-31.
14. Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from descriptions of treatment in trials and reviews? Br Med J. 2008;336(7659):1472-4.
15. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, Altman DG, Barbour V, Macdonald H, Johnston M, Lamb SE, Dixon-Woods M, McCulloch P, Wyatt JC, Chan A, Michie S. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. Br Med J. 2014;348:g1687.
16. Medical Research Council. Developing and evaluating complex interventions: new guidance. 2008.
17. Medical Research Council. Process evaluation of complex interventions: UK Medical Research Council (MRC) guidance. 2015.
18. Grant A, Treweek S, Dreischulte T, Foy R, Guthrie B. Process evaluations for cluster-randomised trials of complex interventions: a proposed framework for design and reporting. Trials. 2013;14(1):15.
19. May C, Finch T. Implementing, embedding, and integrating practices: an outline of normalisation process theory. Sociology. 2009;43:535.
20. Grant A, Dreischulte T, Treweek S, Guthrie B. Study protocol of a mixed-methods evaluation of a cluster randomised trial to improve the safety of NSAID and antiplatelet prescribing: data-driven quality improvement in primary care. Trials. 2012;13:154.
21. Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Administration Policy Mental Health Mental Health Serv Res. 2015;42(5):533-44.
22. Grant A, Sullivan F, Dowell J. An ethnographic exploration of influences on prescribing in general practice: why is there variation in prescribing practices? Implement Sci. 2013;8(1):72.
23. Glaser B, Strauss A. The discovery of grounded theory: strategies for qualitative research. Chicago: Aldine Publishing Co; 1967.
24. Ritchie J, Spencer L, O'Connor W. Carrying out qualitative analysis. In: Ritchie J, Lewis J, editors. Qualitative research practice, a guide for social science students and researchers. London: Sage Publications Ltd; 2003.
25. Ivers NM, Grimshaw JM, Jamtvedt G, Flottorp S, O'Brien MA, French SD, Young J, Odgaard-Jensen J. Growing literature, stagnant science? Systematic review, meta-regression and cumulative analysis of audit and feedback interventions in health care. J Gen Intern Med. 2014;29(11):1534-41.
26. Guthrie B, Kavanagh K, Robertson C, Barnett K, Treweek S, Petrie D, Ritchie L, Bennie M. Data feedback and behavioural change intervention to improve primary care prescribing safety (EFIPPS): multicentre, three arm, cluster randomised controlled trial. BMJ. 2016;354:i4079.
27. Avery AJ, Rodgers S, Cantrill JA, Armstrong S, Cresswell K, Eden M, Elliott RA, Howard R, Kendrick D, Morris CJ, Prescott RJ, Swanwick G, Franklin M, Putman K, Boyd M, Sheikh A. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet. 2012;379(9823):1310-9.
28. Cresswell K, Sadler S, Rodgers S, Avery A, Cantrill J, Murray S, Sheikh A. An embedded longitudinal multi-faceted qualitative evaluation of a complex cluster randomized controlled trial aiming to reduce clinically important errors in medicines management in general practice. Trials. 2012;13(1):78.
29. McCleary N, Duncan E, Stewart F, Francis J. Active ingredients are reported more often for pharmalogic than non-pharmalogic interventions: an illustrative review of reporting practices in titles and abstracts. Trials. 2013;14:146.